Many infectious diseases have dramatically decreased during the last 100 years in developed countries. Meanwhile, epidemiologic statistics indicate an increasing incidence in allergic disorders, like asthma, rhinitis and atopic dermatitis and autoimmune diseases such as type 1 diabetes, multiple sclerosis (MS) and celiac disease.1 As these diseases impact millions of people especially in Western nations,…
We hope you had a relaxing Christmas break – we are now ready to get back to business and start new activities in the project! Towards the end of last year, HEDIMED admin team was busy with submitting the project’s first periodic report, describing the progress carried out during the first 18 months of the…
Introduction Health is greatly determined by the exposome, i.e., environmental exposures one is subjected to throughout their lifetime. With the revolution in genetic techniques in the past decades, we have learned a lot about many of the genetic underpinnings of chronic diseases, e.g., genetics behind heart disease, cancer, type 1, and type 2 diabetes etc….
12-14th of February 2020 In February 2020 the entire HEDIMED consortium gathered together for the first time in a three-day kick-off meeting in Tampere Hall, Tampere, Finland. In a total of 87 participants attended the face-to-face meeting and spent long but productive days getting to know the details of the project and meeting the other…
11th of February 2020 The nine projects of the European Human Exposome Network had a common launching event on February 10th in Brussels. The event took place in the European Commission, Charlemagne building, Room Alcide De Gasperi. It was a one-day fruitful event with keynote speeches by exposome experts, Christopher Wild (Emeritus Director, International Agency…